- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Dixie L. Johnson
Events 11 results
Speaking Engagement
January 31, 2023
Elizabeth Morgan and Dixie Johnson to Speak During the 50th Securities Regulation Institute Conference
Speaking Engagement
June 2, 2022
Dixie Johnson to Speak at 47th ABA National Conference on Professional Responsibility
Speaking Engagement
May 25, 2022
Dixie Johnson to Speak at PLI’s 54th Annual Institute on Securities Regulation
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Speaking Engagement
November 2, 2021
Craig Carpenito, Dixie Johnson, Nikki Reeves, Seth Lundy to Speak at Virtual 22nd Annual Pharmaceutical and Medical Device Ethics and Compliance Congress
Speaking Engagement
January 25, 2021
Dixie Johnson, Richard Walker to Speak on 2021 Securities Regulation Institute’s Virtual Conference
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Speaking Engagement
November 6, 2020
Dixie Johnson, Richard Walker to Speak on Live Webcast of PLI’s 52nd Annual Institute on Securities Regulations
Speaking Engagement
October 28, 2020
Dixie Johnson, Dick Walker to Speak at Securities Enforcement Forum 2020
Conference
June 15, 2016
2016 Compliance Summit
Conference
December 17, 2015
Quarterly Energy Forum